Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Hirsch

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2016
Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin plus necitumumab versus gemcitabine-cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancerL Paz-Ares, M A Socinski, J Shahidi, et al.
Clinical Pharmacology and Therapeutics|February 14, 2015
Innovative Clinical Trials: The LUNG-MAP StudyC E Steuer, V Papadimitrakopoulou, R S Herbst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2002
High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancerR M Bremnes, R Veve, E Gabrielson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2006
Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapyR Dziadziuszko, B Holm, B G Skov, et al.
Journal of the National Cancer Institute|September 20, 2001
Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized studyF R Hirsch, S A Prindiville, Y E Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agentsP A Bunn, B Helfrich, A F Soriano, et al.
Cancer|September 1, 1988
Histopathologic classification of small cell lung cancer. Changing concepts and terminologyF R Hirsch, M J Matthews, S Aisner, et al.
Ugeskrift for Laeger|February 26, 1996
[Mammographic screening in the municipality of Copenhagen. Results of the first screening round]T Jørgensen, L B Jensen, S Duun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancerJ P Neijt, S A Engelholm, M K Tuxen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
The Liverpool Statement 2005: priorities for the European Union/United States spiral computed tomography collaborative groupJ K Field, R A Smith, S W Duffy, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2016
Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin plus necitumumab versus gemcitabine-cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancerL Paz-Ares, M A Socinski, J Shahidi, et al.
Clinical Pharmacology and Therapeutics|February 14, 2015
Innovative Clinical Trials: The LUNG-MAP StudyC E Steuer, V Papadimitrakopoulou, R S Herbst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2002
High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancerR M Bremnes, R Veve, E Gabrielson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2006
Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapyR Dziadziuszko, B Holm, B G Skov, et al.
Journal of the National Cancer Institute|September 20, 2001
Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized studyF R Hirsch, S A Prindiville, Y E Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agentsP A Bunn, B Helfrich, A F Soriano, et al.
Cancer|September 1, 1988
Histopathologic classification of small cell lung cancer. Changing concepts and terminologyF R Hirsch, M J Matthews, S Aisner, et al.
Ugeskrift for Laeger|February 26, 1996
[Mammographic screening in the municipality of Copenhagen. Results of the first screening round]T Jørgensen, L B Jensen, S Duun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancerJ P Neijt, S A Engelholm, M K Tuxen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
The Liverpool Statement 2005: priorities for the European Union/United States spiral computed tomography collaborative groupJ K Field, R A Smith, S W Duffy, et al.
Pageof 8